Testing for hereditary thrombophilia: A retrospective analysis of testing referred to a national laboratory

BMC Clinical Pathology

Volumn 8, Issue 1, 2008, Pages

  Jackson, Brian R ^a,c   Holmes, Kyland ^b   Phansalkar, Amit ^c   Rodgers, George M ^a,c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ARUP LABORATORIES   (United States)

^c ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C; PROTEIN S;

ADULT; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; GENETIC DISORDER; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PROTHROMBIN TIME; QUALITY CONTROL; THROMBOPHILIA;

EID: 42549126874     PISSN: 14726890     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-8-3     Document Type: Article

References (25)

1. HCUPnet, Healthcare Cost and Utilization Project. Agency for Healthcare Research and Quality, Rockville MD, http://hcupnet.ahrq.gov/ Accessed 04/14/2008
2. An evaluation of thrombophilia screening in an urban tertiary care medical center: A "real world" experience. J Somma II Sussman JH Rand, Am J Clin Pathol 2006 126 1 120 127 10.1309/KV06-32LJ-8EDM-EWQT 16753592
3. College of American Pathologists Consensus Conference XXXVI: Diagnostic issues in thrombophilia. Introduction and general considerations. JD Olson, Arch Pathol Lab Med 2002 126 1277 1279 12421135
4. College of American Pathologists. http://www.cap.org Accessed 15 May 2007
5. National Guideline Clearinghouse. Agency for Healthcare Research and Quality, Rockville MD, http://www.guideline.gov Accessed 15 May, 2007
6. Antithrombin deficiency: Issues in laboratory diagnosis. K Kottke-Marchant A Duncan, Arch Pathol Lab Med 2002 126 1326 1336 12421140
7. Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin and endothelial cell protein C receptor. K Kottke-Marchant P Comp, Arch Pathol Lab Med 2002 126 1337 1348 12421141
8. A review of the technical, diagnostic and epidemiologic considerations for protein S assays. AJ Goodwin FR Rosendaal K Kottke-Marchant EG Bovill, Arch Pathol Lab Med 2002 126 1349 1366 12421142
9. Clinical utility of factor V Leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. RD Press KA Bauer JL Kujovich JA Heit, Arch Pathol Lab Med 2002 126 1304 1318 12421138
10. American College of Medical Genetics Consensus Statement on Factor V Leiden Mutation Testing. WW Grody JH Griffin AK Taylor BR Korf JA Heit ACMG Factor V Leiden Working Group, Genet Med 2001 3 2 139 148 11280951
11. Update on selected venous thrombotic disorders. RS Robetorye GM Rodgers, Am J Hematol 2001 68 256 268 10.1002/ajh.10002 11754415
12. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. O Salomon DM Steinberg A Zivelin S Gitel R Dardik N Rosenberg S Berliner A Inbal A Many A Lubetsky D Varon U Martinowitz U Seligsohn, Arterioscler Thromb Vasc Biol 1999 19 511 518 10073951
13. Adjusted P-values for simultaneous inference. SP Wright, Biometrics 1992 48 1005 1013 10.2307/2532694
14. CAP Surveys 2004. College of American Pathologists, Northfield, Ill: College of American Pathologists. Sets MGL-A, MGL-B, CED-A, CED-B, CED-C
15. Use of specialized coagulation testing in the evaluation of patients with acute ischemic stroke. CD Bushnell Z Siddiqi JC Morgenlander LB Goldstein, Neurology 2001 56 624 627 11245714
16. Physician knowledge and practices in the evaluation of coagulopathies in stroke patients. CD Bushnell LB Goldstein, Stroke 2002 33 948 953 10.1161/01.STR.0000014583.17714.E0 11935042
17. nd annual meeting, Abstract 4061. RS Robetorye GM Rodgers, Blood 2000 96 11 88b
18. Thrombophilia, clinical factors, and recurrent venous thrombotic events. SC Christiansen SC Cannegieter T Koster JP Vandenbroucke FR Rosendaal, JAMA 2005 293 19 2352 2361 10.1001/jama.293.19.2352 15900005
19. Hypercoagulation testing in ischemic stroke. A Rahemtullah EM Van Cott, Arch Pathol Lab Med 2007 131 890 901 17550316
20. Thrombophilia and venous thromboembolism: implications for testing. DM Cohn S Roshani S Middeldorp, Semin Thromb Hemost 2007 33 6 573 581 10.1055/s-2007-985753 17768689
21. Who should be tested for thrombophilia? P Simioni, Curr Opin Hematol 2006 13 5 337 343 10.1097/01.moh.0000239705.25050.ff 16888438
22. Testing for thrombophilia: an evidence-based approach. L Merriman M Greaves, Postgrad Med J 2006 82 699 704 10.1136/pgmj.2006.048090 17099087
23. Screening for thrombophilia. D Blickstein, Obstet Gynecol Clin North Am 2006 33 3 389 395 10.1016/j.ogc.2006.05.005 16962916
24. 2005 Clinical Diagnostic Laboratory Fee Schedule. Centers for Medicare and Medicaid Services, Baltimore MD, http://www.cms.hhs.gov/ClinicalLabFeeSched/ 02_clinlab.asp Accessed 04/14/08
25. Translating guidelines into practice. A systematic review of theoretical concepts, practical experience and research evidence in the adoption of clinical practice guidelines. DA Davis A Taylor-Vaisey, Can Med Assoc J 1997 157 4 408 416